Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Valvular prostheses and their follow-up].

G Hanania1

  • 1Service de cardiologie Centre hospitalier Robert-Ballanger 93602 Aulnay-sous-bois. HOP.BALLANGER.CARDIO.@wanadoo.fr

La Revue Du Praticien
|December 16, 2000
PubMed
Summary

Valvular prostheses correct severe heart valve diseases but have drawbacks. Mechanical options require anticoagulation, while bioprostheses degrade, necessitating careful patient monitoring with echocardiography.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The white book of the National College of Hospital Cardiologists (NCHC) -- to respond to a public health issue].

Annales de cardiologie et d'angeiologie·2012
Same author

[Operative risk of heart valve surgery after 80 years].

Annales de cardiologie et d'angeiologie·2006
Same author

Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry.

Heart (British Cardiac Society)·2006
Same author

High risk hypertensives: pre-hospital management of acute myocardial infarction--results from the French nationwide registry USIC 2000.

Annales de cardiologie et d'angeiologie·2006
Same author

[Management of patients admitted for acute myocardial infarction in France from 1995 to 2000: time to admission dependent improvement in outcome].

Archives des maladies du coeur et des vaisseaux·2005
Same author

Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study.

Heart (British Cardiac Society)·2005

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Surgical Innovation

Context:

  • Valvular prostheses have been used since 1961 to treat severe valvular heart disease when conservative methods fail.
  • Current prosthetic valves offer excellent hemodynamic performance.
  • Despite advancements, no single prosthetic valve type is ideal for all patients.

Purpose:

  • To review the current state of valvular prostheses, including their advantages and limitations.
  • To highlight the complications associated with both mechanical and bioprosthetic valves.
  • To emphasize the importance of long-term patient follow-up.

Summary:

  • Mechanical prostheses offer durability but necessitate lifelong anticoagulant therapy.
  • Bioprostheses avoid anticoagulation but are prone to structural deterioration and reoperation.
  • Both types are susceptible to valve-related complications such as thromboembolism and endocarditis.

Impact:

  • Highlights the ongoing need for improved prosthetic valve technology.
  • Underscores the critical role of echocardiography in monitoring patients with heart valve replacements.
  • Informs clinical decision-making regarding the selection and management of patients requiring valvular prostheses.

Related Experiment Videos